Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
EXR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
seekingalpha.com
3 hours ago
https://thefly.com
7 hours ago
seekingalpha.com
7 hours ago
seekingalpha.com
9 hours ago
seekingalpha.com
14 hours ago
prnewswire.com
16 hours ago
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
153.40(7.06%)
Number of analyst
5
Last analyst upgrade/downgrade
Wells Fargo
upgradePrevious: Equal-Weight
2025-08-26
Now: Overweight
Exane BNP Paribas
initialisePrevious: Not converted
2025-06-24
Now: Neutral
Scotiabank
upgradePrevious: Underperform
2025-01-09
Now: Sector Perform
Wells Fargo
downgradePrevious: Neutral
2024-10-21
Now: Equal-Weight
Earnings Growth
YoY
Current
Estimates
Q3.23
+22%
2.02
vs 1.65
Q4.23
+33%
2.02
vs 1.52
Q1.24
+34%
1.96
vs 1.46
Q2.24
+37%
2.06
vs 1.5
Q3.24
+2%
2.07
vs 2.02
Q4.24
+1%
2.03
vs 2.02
Q1.25
+2%
2
vs 1.96
Q2.25
0%
2.05
vs 2.06
Q3.25
-42%
1.19
vs 2.07
Q4.25
-43%
1.16
vs 2.03
Sales Growth
YoY
Current
Estimates
Q3.23
+50%
763.1M vs 510.1M
Q4.23
+57%
814M vs 517.7M
Q1.24
+59%
814.5M vs 513.4M
Q2.24
+58%
827.9M vs 524.6M
Q3.24
+12%
854.8M vs 763.1M
Q4.24
+3%
840.7M vs 814M
Q1.25
+3%
839.9M vs 814.5M
Q2.25
+2%
841.6M vs 827.9M
Q3.25
+2%
871.4M vs 854.8M
Q4.25
+3%
867.9M vs 840.7M
Return on Equity
QoQ
Q1.23
+6%
0.06
vs 0.06
Q2.23
+6%
0.06
vs 0.06
Q3.23
+1%
0.01
vs 0.06
Q4.23
+2%
0.02
vs 0.01
Q1.24
+1%
0.01
vs 0.02
Q2.24
+1%
0.01
vs 0.01
Q3.24
+1%
0.01
vs 0.01
Q4.24
+2%
0.02
vs 0.01
Q1.25
+2%
0.02
vs 0.02
Q2.25
+2%
0.02
vs 0.02
Institutionnal Ownership
QoQ
Q1.23
596
596
vs 603
-1%
Q2.23
596
596
vs 596
NA
Q3.23
674
674
vs 596
13%
Q4.23
728
728
vs 674
8%
Q1.24
724
724
vs 728
-1%
Q2.24
760
760
vs 724
5%
Q3.24
782
782
vs 760
3%
Q4.24
792
792
vs 782
1%
Q1.25
805
805
vs 792
2%
Q2.25
796
796
vs 805
-1%
Quote Panel
Key Metrics
Relative Strength
EXR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|